In 2006, a 2.5-year-old girl with longstanding history of unexplained tachypnea, retractions, hypoxemia, and intermittent crackles on physical exam was seen in consultation. She had undergone batteries of testing at multiple institutions, including repeated sweat chloride testing, bronchoscopy, nasal potential difference testing, ciliary biopsies, video swallow studies, chest CT scans, and more. She had a Cushingoid appearance from chronic corticosteroids which had not clearly improved her respiratory status. After her diagnosis of wileyonlinelibrary.com/journal/ppul Pediatric Pulmonology. 2018;53:1336-1337.presence. Lastly, a key limitation is that this questionnaire has not yet been evaluated for test-retest use over time. Such investigation is critical to determining whether this tool can be employed longitudinally to assess quality of life with respect to disease progression and in response to therapeutic interventions.In summary, most providers recognize that childhood ILD has profound impact on patients and families, but we struggle with how to measure the outcomes. Neimitz and colleagues are commended for taking the first steps to measure what matters most to our patients and families.
ORCIDRebekah J. Nevel http://orcid.org/0000-0001-9386-3398Lisa R. Young